Exploiting the vascular protective effects of high-density lipoprotein and its apolipoproteins. An idea whose time for testing is coming, part I

Saved in:
Bibliographic Details
Published inCirculation (New York, N.Y.) Vol. 104; no. 19; pp. 2376 - 2383
Main Authors SHAH, Prediman K, KAUL, Sanjay, NILSSON, Jan, CERCEK, Bojan
Format Journal Article
LanguageEnglish
Published Hagerstown, MD Lippincott Williams & Wilkins 06.11.2001
American Heart Association, Inc
Subjects
Animals
Apolipoprotein A-I - blood
apolipoproteins
Apolipoproteins - blood
Apolipoproteins - pharmacology
Arteriosclerosis - blood
Arteriosclerosis - etiology
Arteriosclerosis - prevention & control
atherosclerosis
Atherosclerosis (general aspects, experimental research)
Biological and medical sciences
Biological Transport
Blood and lymphatic vessels
Cardiac and Cardiovascular Systems
Cardiology. Vascular system
Clinical Medicine
Endothelium, Vascular - drug effects
Fibrinolysis - drug effects
Health Behavior
Humans
Hyperlipidemias - blood
Hyperlipidemias - complications
Inflammation - prevention & control
Kardiologi
Klinisk medicin
lipoproteins
Lipoproteins, HDL - blood
Lipoproteins, HDL - pharmacology
Lipoproteins, LDL - adverse effects
Lipoproteins, LDL - blood
Lysophosphatidylcholines - antagonists & inhibitors
Lysophosphatidylcholines - metabolism
Medical and Health Sciences
Medical sciences
Medicin och hälsovetenskap
Oxidation-Reduction
Thrombosis - prevention & control
Vascular disease
Human
Prevention
Treatment
Pathophysiology
Treatment efficiency
Atherosclerosis
Lipids
Cardiovascular disease
Apolipoprotein
Review
Lipoprotein HDL
Online AccessGet full text

Cover

More Information
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:0009-7322
1524-4539
1524-4539
DOI:10.1161/hc4401.098467